Atrial fibrillation
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: The subjects selected for this study must meet all the following conditions: 1) Age >= 40 years old and = 2 hours; 7) RFCA is feasible after comprehensive clinical evaluation by cardiologists in the research group; 8) Consent to participate in this study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: Subjects with any of the following conditions cannot be included in this study: 1. Those who refuse to participate in this study. 2. Those with a history of schizophrenia, epilepsy, Parkinson's disease, or depression. 3. Those who are unable to complete the pre-operative assessment due to severe dementia, speech disorders, coma, end-stage diseases, etc. 4. Critically ill patients (patients with an American Society of Anesthesiologists (ASA) preoperative classification of >= Grade IV, see Annex 1); those with severe renal impairment (patients requiring renal replacement therapy); those with severe liver function impairment (Child-Pugh Class C) (see Annex 2). 5. Permanent atrial fibrillation that cannot be electrically cardioverted. 6. Atrial fibrillation associated with valvular disease. 7. Structural heart disease with left ventricular hypertrophy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The recurrence situation of atrial fibrillation in the near and long term after transcatheter radiofrequency ablation.;Plasma norepinephrine and acetylcholine concentrations; | — |
Secondary
| Measure | Time frame |
|---|---|
| Comorbidities before surgery, the type of atrial fibrillation, the method of transcatheter ablation, the use of anti-arrhythmic drugs (AAD) or the situation of taking the drugs again; | — |
Countries
China
Contacts
People's Hospital of Ningxia Hui Autonomous Region